Inspiremd to participate in upcoming november investor conferences

Tel aviv, israel and miami, fla., nov. 02, 2023 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ embolic prevention stent system (eps) for treatment of carotid artery disease and prevention of stroke, today announced that the marvin slosman, chief executive officer, will participate in three upcoming investor conferences in november:
NSPR Ratings Summary
NSPR Quant Ranking